SPRO - スマ―トプロス (Spero Therapeutics Inc.)

SPROのニュース

   Spero Therapeutics (NASDAQ:SPRO) Shares Cross Below Two Hundred Day Moving Average of $15.95  2021/12/14 08:30:42 Dakota Financial News
Shares of Spero Therapeutics, Inc. (NASDAQ:SPRO) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $15.95 and traded as low as $13.27. Spero Therapeutics shares last traded at $13.65, with a volume of 107,572 shares trading hands. Several brokerages have recently issued reports on SPRO. […]
   California State Teachers Retirement System Grows Position in Spero Therapeutics, Inc. (NASDAQ:SPRO)  2021/11/30 09:32:44 Dakota Financial News
California State Teachers Retirement System grew its stake in Spero Therapeutics, Inc. (NASDAQ:SPRO) by 8.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,446 shares of the companys stock after purchasing an additional 2,523 shares during the period. California State []
   Spero Therapeutics to Present at Upcoming Investor Conferences  2021/11/17 13:05:00 Intrado Digital Media
CAMBRIDGE, Mass., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced that Ankit Mahadevia, M.D., President and Chief Executive Officer of Spero Therapeutics, will present and be available for one-on-one meetings at the Piper Sandler 33 rd Annual Virtual Healthcare Conference and the 4 th Annual Evercore ISI HealthCONx Conference, which are taking place virtually, November 29, 2021 through December 2, 2021 and November 30, 2021 through December 2, 2021, respectively. Details for the presentations are as follows.
   Vanguard Group Inc. Boosts Stock Holdings in Spero Therapeutics, Inc. (NASDAQ:SPRO)  2021/11/13 09:30:41 Dakota Financial News
Vanguard Group Inc. boosted its stake in shares of Spero Therapeutics, Inc. (NASDAQ:SPRO) by 15.4% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,276,790 shares of the companys stock after purchasing an additional 170,094 shares during the period. Vanguard Group Inc.s []
   Spero Therapeutics, Inc. (SPRO) CEO Ankit Mahadevia on Q3 2021 Results - Earnings Call Transcript  2021/11/11 03:15:03 Seeking Alpha
   Spero Therapeutics (NASDAQ:SPRO) Shares Cross Below Two Hundred Day Moving Average of $15.95  2021/12/14 08:30:42 Dakota Financial News
Shares of Spero Therapeutics, Inc. (NASDAQ:SPRO) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $15.95 and traded as low as $13.27. Spero Therapeutics shares last traded at $13.65, with a volume of 107,572 shares trading hands. Several brokerages have recently issued reports on SPRO. […]
   California State Teachers Retirement System Grows Position in Spero Therapeutics, Inc. (NASDAQ:SPRO)  2021/11/30 09:32:44 Dakota Financial News
California State Teachers Retirement System grew its stake in Spero Therapeutics, Inc. (NASDAQ:SPRO) by 8.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,446 shares of the companys stock after purchasing an additional 2,523 shares during the period. California State []
   Spero Therapeutics to Present at Upcoming Investor Conferences  2021/11/17 13:05:00 Intrado Digital Media
CAMBRIDGE, Mass., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced that Ankit Mahadevia, M.D., President and Chief Executive Officer of Spero Therapeutics, will present and be available for one-on-one meetings at the Piper Sandler 33 rd Annual Virtual Healthcare Conference and the 4 th Annual Evercore ISI HealthCONx Conference, which are taking place virtually, November 29, 2021 through December 2, 2021 and November 30, 2021 through December 2, 2021, respectively. Details for the presentations are as follows.
   Vanguard Group Inc. Boosts Stock Holdings in Spero Therapeutics, Inc. (NASDAQ:SPRO)  2021/11/13 09:30:41 Dakota Financial News
Vanguard Group Inc. boosted its stake in shares of Spero Therapeutics, Inc. (NASDAQ:SPRO) by 15.4% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,276,790 shares of the companys stock after purchasing an additional 170,094 shares during the period. Vanguard Group Inc.s []
   Spero Therapeutics, Inc. (SPRO) CEO Ankit Mahadevia on Q3 2021 Results - Earnings Call Transcript  2021/11/11 03:15:03 Seeking Alpha
   California State Teachers Retirement System Grows Position in Spero Therapeutics, Inc. (NASDAQ:SPRO)  2021/11/30 09:32:44 Dakota Financial News
California State Teachers Retirement System grew its stake in Spero Therapeutics, Inc. (NASDAQ:SPRO) by 8.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,446 shares of the companys stock after purchasing an additional 2,523 shares during the period. California State []
   Spero Therapeutics to Present at Upcoming Investor Conferences  2021/11/17 13:05:00 Intrado Digital Media
CAMBRIDGE, Mass., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced that Ankit Mahadevia, M.D., President and Chief Executive Officer of Spero Therapeutics, will present and be available for one-on-one meetings at the Piper Sandler 33 rd Annual Virtual Healthcare Conference and the 4 th Annual Evercore ISI HealthCONx Conference, which are taking place virtually, November 29, 2021 through December 2, 2021 and November 30, 2021 through December 2, 2021, respectively. Details for the presentations are as follows.
   Vanguard Group Inc. Boosts Stock Holdings in Spero Therapeutics, Inc. (NASDAQ:SPRO)  2021/11/13 09:30:41 Dakota Financial News
Vanguard Group Inc. boosted its stake in shares of Spero Therapeutics, Inc. (NASDAQ:SPRO) by 15.4% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,276,790 shares of the companys stock after purchasing an additional 170,094 shares during the period. Vanguard Group Inc.s []
   Spero Therapeutics, Inc. (SPRO) CEO Ankit Mahadevia on Q3 2021 Results - Earnings Call Transcript  2021/11/11 03:15:03 Seeking Alpha
   Spero Therapeutics EPS misses by $0.04, misses on revenue  2021/11/10 21:27:03 Seeking Alpha

calendar